| Expression pattern: |
DN |
| Associated gene: |
HECW2 |
| Associated microRNA: |
hsa‐miR‐4778‐5p, hsa‐miR‐5690, hsa‐miR‐1200, hsa‐miR‐619‐5p, hsa‐miR‐212‐5p |
| Biological function: |
Associated with prognosis; low expression indicates poor prognosis in LCXW. |
| Molecular mechanism: |
May function via absorbing predicted miRNAs (miRNA sponge); investigated host gene HECW2 with no expression correlation. |
| Biological pathway or process: |
ceRNA regulation (other); other pathway/process (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RNase R Treatment; RT-qPCR; Sanger Sequencing; Clinical Sample Validation; Survival Analysis |
| Clinical significance: |
Related to prognosis of LCXW patients; may serve as a novel potential biomarker for LCXW and for evaluating prognosis. |
| Description: |
hsa_circRNA_406010 is significantly down-regulated in LCXW tumor tissues and lower expression is associated with poor prognosis. It is an intronic circRNA linked to host gene HECW2 (no expression correlation observed) and is predicted to sponge several miRNAs, supporting its potential as a prognostic biomarker. |
| Confidence score: |
0.63 |